TSC22 domain family, member 1 (TSC22D1) is one of the TGF-beta-stimulated clone-22 (TSC-22). TSC-22 was reported to be a differentiation-inducing factor that negatively regulates the growth of salivary gland cancer cells. TSC22D1, which encodes transforming growth factor beta-stimulated clone 22 (TSC-22), is thought to be a tumor suppressor because its expression is lost in many glioblastoma, salivary gland, and prostate cancers. TSC-22 is the founding member of the TSC-22/DIP/Bun family of leucine zipper transcription factors. TSC-22 may play an important role in maintaining the differentiated phenotype in salivary gland tumors, and may be a possible target of leukemia therapy. TSC22D1 forms homodimers via its conserved leucine zipper domain and heterodimerizes with TSC22D4. TSC22D1 has transcriptional repressor activity.
Stoccaggio: This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
Isotipo: IgG
Clonalità: Monoclonal
Clone: 4B3
Coniugazione: Unconjugated
Applicazione: ICC/IF
Diluizione: ICC/IF 1:20-1:100
Simbolo target: TSC22D1
Ig target: TSC;Ptg;KIAA;hucep;TGFB1I;Tsc22d;Ptg-2;KIAA1994;TGFB1I4;TSC22;TSC22D1;hucep-2;TSC22 domain family member 1
Area di ricerca:Epigenetics and Nuclear Signaling
Newsletter TEMA RICERCA
Ricevi aggiornamenti davvero rilevanti per il tuo ambito
Inserisci la tua e-mail e seleziona le aree di interesse per ricevere le ultime novità, approfondimenti e promozioni.